您的位置: 首页 > 农业专利 > 详情页

DÉRIVÉ DE BIGUANIDE, PROCÉDÉ DE PRÉPARATION DE CELUI-CI ET COMPOSITION PHARMACEUTIQUE CONTENANT LE DÉRIVÉ DE BIGUANIDE EN TANT QUE SUBSTANCE ACTIVE
专利权人:
LTD.;HANALL BIOPHARMA CO.
发明人:
KIM, SUNG WUK,JUN, SUNG SOO,MIN, CHANG HEE,KIM, YOUNG WOONG,KANG, MIN SEOK,OH, BYUNG KYU,PARK, SE HWAN,KIM, YONG EUN,KIM, DUCK,LEE, JI SUN,OH, JU HOON
申请号:
EP11731936
公开号:
EP2522653A4
申请日:
2011.01.06
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
A biguanide derivative compound with N4-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK and inhibition of cancer cell proliferation in a low dose, compared with conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充